|
1
|
Boyle P and Levin B; International Agency
for Research on Cancer and World Health Organization. World Cancer
Report 2008. International Agency for Research on Cancer. WHO
Press; Lyon/Geneva: 2008
|
|
2
|
Bosman FT; World Health Organization and
International Agency for Research on Cancer. WHO Classification of
Tumours of the Digestive System. 4th edition. Bosman FT, Carneiro
F, Hruban RH and Theise ND: International Agency for Research on
Cancer; Lyon: 2010
|
|
3
|
Go PH, Klaassen Z, Meadows MC and
Chamberlain RS: Gastrointestinal cancer and brain metastasis: a
rare and ominous sign. Cancer. 117:3630–3640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang S, Wang M, Xue YH and Chen YP:
Cerebral metastasis from hepatoid adenocarcinoma of the stomach.
World J Gastroenterol. 13:5787–5793. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oh SY, Lee SJ, Lee J, et al: Gastric
leptomeningeal carcinomatosis: multi-center retrospective analysis
of 54 cases. World J Gastroenterol. 15:5086–5090. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tomita H, Yasui H, Boku N, et al:
Leptomeningeal carcinomatosis associated with gastric cancer. Int J
Clin Oncol. 17:361–366. 2011. View Article : Google Scholar
|
|
7
|
Lee JL, Kang YK, Kim TW, et al:
Leptomeningeal carcinomatosis in gastric cancer. J Neurooncol.
66:167–174. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gazzeri R, Galarza M, Neroni M and Gaaaeri
G: Central Nervous System Metastases From Gastric Cancer. Research
Focus on Gastric Cancer. Cardinni DC: Nova Science Publishers,
Inc.; Hauppauge, NY: pp. 165–183. 2007
|
|
9
|
Bartolotti M, Franceschi E and Brandes AA:
EGF receptor tyrosine kinase inhibitors in the treatment of brain
metastases from non-small-cell lung cancer. Expert Rev Anticancer
Ther. 12:1429–1435. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Patel RR and Mehta MP: Targeted therapy
for brain metastases: improving the therapeutic ratio. Clin Cancer
Res. 13:1675–1683. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weil RJ: Does trastuzumab increase the
risk of isolated central nervous system metastases in patients with
breast cancer? Nat Clin Pract Oncol. 3:236–237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bang YJ, Van Cutsem E, Feyereislova A, et
al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER2-positive advanced gastric
or gastrooesophageal junction cancer (ToGA): a phase 3, open-label,
randomised controlled trial. Lancet. 376:687–697. 2010. View Article : Google Scholar
|
|
13
|
Ohtsu A, Shah MA, Van Cutsem E, et al:
Bevacizumab in combination with chemotherapy as first-line therapy
in advanced gastric cancer: a randomized, double-blind,
placebo-controlled phase III study. J Clin Oncol. 29:3968–3976.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs - the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Osawa S, Shimada Y, Sekine S, et al:
MicroRNA profiling of gastric cancer patients from formalin-fixed
paraffin-embedded samples. Oncol Lett. 2:613–619. 2011.PubMed/NCBI
|
|
17
|
Liu A and Xu X: MicroRNA isolation from
formalin-fixed, paraffin-embedded tissues. Methods Mol Biol.
724:259–267. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol
Chem. 283:14910–14914. 2008. View Article : Google Scholar
|
|
19
|
Song JH and Meltzer SJ: MicroRNAs in
pathogenesis, diagnosis, and treatment of gastroesophageal cancers.
Gastroenterology. 143:35–47. e322012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cong N, Du P, Zhang A, et al:
Downregulated microRNA-200a promotes EMT and tumor growth through
the wnt/β-catenin pathway by targeting the E-cadherin repressors
ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep. 29:1579–1587.
2013.PubMed/NCBI
|
|
21
|
Nathoo N, Chahlavi A, Barnett GH and Toms
SA: Pathobiology of brain metastases. J Clin Pathol. 58:237–242.
2005. View Article : Google Scholar
|
|
22
|
Klopfleisch R, Weiss AT and Gruber AD:
Excavation of a buried treasure - DNA, mRNA, miRNA and protein
analysis in formalin fixed, paraffin embedded tissues. Histol
Histopathol. 26:797–810. 2011.PubMed/NCBI
|
|
23
|
Shen R, Pan S, Qi S, Lin X and Cheng S:
Epigenetic repression of microRNA-129–2 leads to overexpression of
SOX4 in gastric cancer. Biochem Biophys Res Commun. 394:1047–1052.
2010.
|
|
24
|
Zhang Z, Liu S, Shi R and Zhao G: miR-27
promotes human gastric cancer cell metastasis by inducing
epithelial-to-mesenchymal transition. Cancer Genet. 204:486–491.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gregory PA, Bert AG, Paterson EL, et al:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jia B, Liu H, Kong Q and Li B:
Overexpression of ZEB1 associated with metastasis and invasion in
patients with gastric carcinoma. Mol Cell Biochem. 366:223–229.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai YH, Tang YP, Zhu HY, et al: ZEB2
promotes the metastasis of gastric cancer and modulates epithelial
mesenchymal transition of gastric cancer cells. Dig Dis Sci.
57:1253–1260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van de Putte T, Maruhashi M, Francis A, et
al: Mice lacking ZFHX1B, the gene that codes for
Smad-interacting protein-1, reveal a role for multiple neural crest
cell defects in the etiology of Hirschsprung disease-mental
retardation syndrome. Am J Hum Genet. 72:465–470. 2003.
|
|
30
|
Comijn J, Berx G, Vermassen P, et al: The
two-handed E box binding zinc finger protein SIP1 downregulates
E-cadherin and induces invasion. Mol Cell. 7:1267–1278. 2001.
View Article : Google Scholar
|
|
31
|
Cruz-Munoz W and Kerbel RS: Preclinical
approaches to study the biology and treatment of brain metastases.
Semin Cancer Biol. 21:123–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Daphu I, Sundstrom T, Horn S, et al: In
vivo animal models for studying brain metastasis: value and
limitations. Clin Exp Metastasis. 30:695–710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ryu HS, Park do J, Kim HH, Kim WH and Lee
HS: Combination of epithelial-mesenchymal transition and cancer
stem cell-like phenotypes has independent prognostic value in
gastric cancer. Hum Pathol. 43:520–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
